The global Intravenous Solutions market size is expected to be worth around US$ 18.10 billion by 2030, according to a new report by Vision Research Reports.
The global Intravenous Solutions market size was valued at US$ 12.1 billion in 2020 and is anticipated to grow at a CAGR of 7.10% during forecast period 2021 to 2030.
The prevalence of malnutrition, especially among the elderly population due to chronic diseases such as cancer is expected to boost demand for IV solutions in the years to come. Dehydration is one of the common side effects of cancer. Chemotherapy causes dehydration due to side effects, such as vomiting, diarrhea, or excessive urination, which boosts the need for IV hydration.
Intravenous solutions constitute a vital part of the U.S. healthcare system, enabling doctors and nurses to help hydrate their patients, replace lost blood volume, and administer drugs. However, in recent years, the country’s supplies have been severely affected due to longer and more dangerous influenza seasons and destructive weather events. The intravenous solutions shortages have approached crisis levels, forcing healthcare providers to either delay patient treatment or use an alternate technique. In the U.S., IV solutions are provided by a small number of suppliers. Baxter and B. Braun Medical supply most of the IV solutions in the country. Production or quality issues at the manufacturing facilities of these companies cause the overall shortage of IV solutions in the country. Thus, high growth chances lie ahead for intravenous solutions manufacturers to bridge the demand-supply gap.
The TPN segment dominated the market and accounted for the largest revenue share of about 65.8% in 2020 and is projected to continue its dominance over the forecast period. Based on the type of nutrition, the market is segmented into Total Parenteral Nutrition (TPN) and Peripheral Parenteral Nutrition (PPN).
The TPN segment is also projected to grow rapidly owing to its increased importance in the treatment of chronic inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, which affects around 1.6 million in the U.S. each year. TPN helps maintain adequate nutrition in the body and correct malnutrition in patients with dysfunctional digestive systems.
The single dose amino acid solution segment dominated the market and accounted for the largest revenue share of about 31.4% in 2020 and is projected to continue its dominance over the forecast period. Based on nutrients, the market is segmented into carbohydrates, single dose amino acid solution, vitamins and minerals (salt and electrolyte), parenteral lipid emulsion.
The rising prevalence of kidney failure, protein deficiency diseases (Marasmus and kwashiorkor), and hepatic diseases is contributing to the high consumption of amino acid injections. Moreover, increased approvals of enhanced with fewer adverse effects are also fueling the market growth.
The vitamins and minerals (salts and electrolytes) segment is expected to witness the highest CAGR of 9.7% over the forecast period. Key factors contributing to its elevated growth include an increasing number of surgeries and post-operative nutritional management; treatment of diseases, such as anemia, beriberi, and pellagra, and chronic mental conditions; and replacement therapies.
Based on geography, North America dominated the market and accounted for the largest revenue share of 40.8% in 2020.The U.S. is the most important market and accounts for the maximum revenue share in the region. The country is backed by a leading player, Baxter, which supplies around 50.0% of the IV solutions in hospitals across the country. However, the country still faces a shortage of intravenous (IV) solutions, due to influenza seasons, highlighting the need for intravenous (IV) solutions in the country.
Asia Pacific is projected to be the fastest growing region during the forecast period with India being one of the fastest-growing nations.24% of the global preterm births occur in India, which represents a total of 3.5 million preterm births every year. Infants born premature are at a higher risk poor growth and catching infections. Hence, early parenteral nutrition is vital for preterm infants and must supply adequate amino acids and energy. Thus, India is expected to be a key revenue generator for the intravenous (IV) solutions market in the coming years.
B. Braun Melsungen AG
Total Parenteral Nutrition (TPN)
Peripheral Parenteral Nutrition (PPN)
Single Dose Amino Acid Solution
Vitamins & Minerals (Salt and electrolyte)
Parenteral Lipid Emulsion
Middle East & Africa
The Intravenous Solutions market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Intravenous Solutions market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Intravenous Solutions market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Intravenous Solutions market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Intravenous Solutions market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Intravenous Solutions capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Intravenous Solutions by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Intravenous Solutions market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Intravenous Solutions market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Intravenous Solutions market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Intravenous Solutions industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Intravenous Solutions market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Intravenous Solutions market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Intravenous Solutions market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Intravenous Solutions market. These factors have benefited the growth of the global market for Intravenous Solutions. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Intravenous Solutions. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Intravenous Solutions are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Arrhythmia Monitoring Devices Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030Read more...
Vaginitis Therapeutics Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030Read more...
Botanicals Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030Read more...
Stereotactic Surgery Devices Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Biopharmaceuticals Manufacturing Consumables Testing Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...